Search

Developing community eye care: the evolution of Wales’ eye care services

In the third in our series about community eye care in the home nations, David O’Sullivan explains how Wales has developed its community eye care services. Since the devolution of healthcare to Wales on 1 July 1999 [1], significant changes...

Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...

Ophthalmic mentors: Professor Carrie MacEwen

Caroline (Carrie) MacEwen is a Consultant Ophthalmologist at Ninewells Hospital and Medical School, Dundee, and Head of the Ophthalmology Department at the University of Dundee (Honorary Professor). She trained in Glasgow, Dundee and London. Carrie took over as President of...

Specialty-driven EMR for paperless clinical environment – insights for an informed choice

Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...

Celebrating eight years of the nurse-led intravitreal injection service

Moorfields Eye Hospital NHS Foundation Trust in London celebrated the eighth year of its nurse-led intravitreal (IVT) injection service in 2020. In collaboration with Beaver-Visitec International (BVI), Moorfields’ comprehensive one-day course for non-medical staff has blossomed into a thriving success....

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...

Reflections on a twelve-year partnership: The Makassar-Dundee LINK

In the first article of a two-part series (see Part 2 here), the authors provide an overview of this hugely successful partnership and how they overcame the challenges of COVID-19. What began in 2008 as a connection between equals, has...

Flashes and floaters in community optometry – diagnosing a posterior vitreous detachment

Managing patients who attend a practice with symptoms of flashes and floaters is a regular occurrence in community optometric practice. It’s often very distressing for patients; symptoms can be quite dramatic and an internet search can indicate imminent blindness from...

FAQs about cerebral visual impairment (CVI): identifying and helping those affected

Cerebral visual impairment is common in both adults and children, yet the diagnosis can easily be missed unless one is tuned into the presenting features. This article provides a succinct introduction to this important topic. What is vision? Vision is...

The Eye Health Network – an ‘optometry-first’ approach to eye care

Historically, in NHS Grampian, ophthalmology and optometry worked separately, with even the process of optometry referral to hospital occurring only at the behest of the patient’s general practitioner (GP). Criteria for referral were not discussed and feedback after referral was...

Developing community eye care: the GOS package in Scotland

In the second in the series about community eye care in the home nations, Janet Pooley explains how Scotland has developed its services within GOS. The United Kingdom has devolved healthcare; the powers were transferred from Westminster to Scotland and...